| Secondary |
| Drug Use For Unknown Indication |
45.2% |
| Hypertension |
7.9% |
| Pain |
5.6% |
| Product Used For Unknown Indication |
4.8% |
| Acute Myocardial Infarction |
4.0% |
| Prophylaxis |
4.0% |
| Diabetes Mellitus |
3.2% |
| Hypercholesterolaemia |
3.2% |
| Bronchitis |
2.4% |
| Lung Disorder |
2.4% |
| Metastases To Bone |
2.4% |
| Myocardial Infarction |
2.4% |
| Angina Pectoris |
1.6% |
| Essential Hypertension |
1.6% |
| Gout |
1.6% |
| Hypersensitivity |
1.6% |
| Platelet Aggregation |
1.6% |
| Polycythaemia Vera |
1.6% |
| Prostate Cancer |
1.6% |
| Respiratory Disorder |
1.6% |
|
| Toxic Skin Eruption |
12.9% |
| Haematuria |
9.7% |
| Pancytopenia |
6.5% |
| Renal Failure |
6.5% |
| Seborrhoeic Keratosis |
6.5% |
| Sensation Of Heaviness |
6.5% |
| Systemic Inflammatory Response Syndrome |
6.5% |
| T-cell Lymphoma Stage Iv |
6.5% |
| Atrioventricular Block Complete |
3.2% |
| Haemoglobin Decreased |
3.2% |
| Haemolytic Anaemia |
3.2% |
| Hypokalaemia |
3.2% |
| Iga Nephropathy |
3.2% |
| Primary Hypogonadism |
3.2% |
| Rash Morbilliform |
3.2% |
| Rectal Haemorrhage |
3.2% |
| Retroperitoneal Haematoma |
3.2% |
| Splenectomy |
3.2% |
| Subdural Haematoma |
3.2% |
| Tachycardia |
3.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.8% |
| Hypertension |
11.5% |
| Product Used For Unknown Indication |
6.0% |
| Multiple Myeloma |
5.5% |
| Hiv Infection |
4.2% |
| Prophylaxis |
3.9% |
| Thrombosis Prophylaxis |
3.9% |
| Breast Cancer |
3.4% |
| Hypercholesterolaemia |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Diabetes Mellitus |
2.8% |
| Myocardial Infarction |
2.7% |
| Back Pain |
2.4% |
| Coronary Artery Disease |
2.4% |
| Acute Myocardial Infarction |
2.2% |
| Angina Pectoris |
2.2% |
| Depression |
2.2% |
| Anxiety |
2.1% |
| Dyslipidaemia |
1.9% |
| Asthma |
1.5% |
|
| Renal Failure Acute |
11.2% |
| Myocardial Infarction |
9.0% |
| Hyponatraemia |
7.9% |
| Spinal Osteoarthritis |
5.6% |
| Syncope |
5.6% |
| Vomiting |
5.6% |
| Hepatic Encephalopathy |
4.5% |
| Malnutrition |
4.5% |
| Off Label Use |
4.5% |
| Thrombocytopenia |
4.5% |
| Toxic Encephalopathy |
4.5% |
| Toxic Skin Eruption |
4.5% |
| Ventricular Fibrillation |
4.5% |
| Coronary Artery Thrombosis |
3.4% |
| Mitral Valve Incompetence |
3.4% |
| Normochromic Normocytic Anaemia |
3.4% |
| Prostatitis |
3.4% |
| Rhabdomyolysis |
3.4% |
| Somnolence |
3.4% |
| Sudden Death |
3.4% |
|
| Interacting |
| Anticoagulant Therapy |
75.0% |
| Renal Cancer Metastatic |
25.0% |
|
|
